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Management of prosthetic valve thrombosis without
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Transthoracic echocardiographyWe have recently read with great interest the article by
Hariram describing the percutaneous management of pros-
thetic mitral valve thrombosis (PMVT).1 The author evaluated
five consecutive patients with obstructive PMVT who did not
respond to thrombolysis. Although patients were subjected to
percutaneous manipulation of the prosthetic valves success-
fully, we want to address some points that merit more
attention.
Prosthetic heart valve thrombosis is a life-threatening
complication whose management remains controversial.
Although review of literature for management of prosthetic
valve thrombosis reveals no set guidelines, thrombolytic
therapy, thrombectomy, or prosthetic valve replacement are
the currently available options. In the current article, diag-
nosis of PMVTmade on transthoracic echocardiography (TTE).
Although the examination of a patient with prosthetic valve
by TTE is an essential part of diagnostic assessment, the value
of TTE is usually limited because the prosthesis produces a
certain degree of acoustic shadowing. Transesophageal
echocardiography (TEE) along with clinical parameters can
usually differentiate thrombus from pannus formation and
vegetation. TEE can also help to assess thrombus size and
location by its high-resolution imaging and can aid in treat-
ment decisions, such as thrombolysis, anticoagulation, and
surgery.2 Compared with TTE, multiplane TEE provides su-
perior assessment of the left atrium and left atrial appendage
in the majority of patients.DOI of original article: http://dx.doi.org/10.1016/j.ihj.2014.05.
008.Thromboembolic events are a known complication of
cardiac catheterisation procedures or thrombolytic therapy of
PMVT. Especially patients with thrombotic material in the left
atrium are at increased risk of systemic thromboembolism
when treated with thrombolytic therapy or when they un-
derwent cardiac catheterisation.3
Presence of a large left atrial thrombus is accepted as a
contraindication for thrombolysis or most of the cardiac
catheterisation procedures and should be ruled out by TEE
before thrombolytic treatment.4 In the current case report the
author performed thrombolysis and percutaneous manipu-
lation of the guiding catheter across the mitral prosthetic
valve leaflet without prior TEE examination.
In the general population, recent data have shown that
thrombolysis is superior to surgery even in the most critical
patients with prosthetic valve thrombosis.4 Although there
are a lack of randomized controlled prospective trials
comparing surgical and thrombolytic therapies in prosthetic
heart valve thrombosis we have previously shown that
intravenous slow infusion thrombolysis given in discrete,
successive sessions guided by serial TEE can be achieved
with a low risk of complications and a high rate of success
even in patients within New York Heart Association class III
or IV.4,5
In conclusion, we think that while these patients
were fortunatedthey did not suffer any detectable
complicationsda good outcome in 5 patients certainly does
not prove that the approach the author used is broadly
applicable. The risk of catheter manipulation dislodging pre-
existing thrombi may be greater than Hariram think. Ideally,
TEE should be performed before the thrombolytic therapy or
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and low-dose slow infusion of alteplase under the guidance of
serial TEE should be the first-line therapy for PMVT patients
unless contraindicated.r e f e r e n c e s
1. Hariram V. Percutaneous management of prosthetic valve
thrombosis. Indian Heart J. 2014;66:427e429.
2. Biteker M, Duran NE, Gu¨ndu¨z S, et al. Thrombolysis of an acute
prosthetic mitral valve thrombosis presented with cardiogenic
shock under the guidance of continuous transoesophageal
monitoring. Eur J Echocardiogr. 2009;10:468e470.
3. Duran NE, Biteker M, Ozkan M. Coexistence of obstructive
mechanical mitral valve and left atrial thrombosis. Turk
Kardiyol Dern Ars. 2008 Sep;36:426.
4. €Ozkan M, Gu¨ndu¨z S, Biteker M, et al. Comparison of different
TEE-guided thrombolytic regimens for prosthetic valve
thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 2013;6:
206e216.
5. Biteker M, Ozkan M. Treatment of obstructive prosthetic heart
valve thrombosis in pregnancy. J Card Surg. 2010;25:206.Volkan Dogan
Mugla Sıtkı Koc¸man University, Faculty of Medicine, Department of
Cardiology, Turkey
Kadir Ugur Mert*
Mugla Sıtkı Koc¸man University, Faculty of Medicine, Department of
Cardiology, Turkey
Murat Biteker
Associate Prof, Mugla Sıtkı Koc¸man University, Faculty of Medicine,
Department of Cardiology, Turkey
*Corresponding author. Mugla Sıtkı Koc¸man U¨niversitesi Tıp
Faku¨ltesi, Orhaniye Mah. Haluk €Ozsoy Cad. 48000/MUGLA,
Turkey. Tel.: þ90 252 214 13 26.
E-mail address: kugurmert@gmail.com0019-4832/$ e see front matter
Copyright © 2015, Cardiological Society of India. All rights
reserved.
http://dx.doi.org/10.1016/j.ihj.2015.02.021Letter to the EditorDear sir,
Read with great interest your article in the IHJ on the ‘ills of
current medical practice’. I believe you have held the pulse of the
topic excepting highlighting the following factors:1. Impact of fees in private medical
institutions on minds of young doctors
When I was a medical student 1987 or so, there were very few
capitation based medical training institutes. Hence the
number of graduates from these institutions were also few-
most were wards of rich parents who did not bother
spending money. This payment of hefty fees was not a
compulsion. This is in contrast to the scenario today where
parents are forced to pay capitation fees out of compulsion; to
find space to train their wards-to exemplify-a doctor working
as a chief medical officer in a small hospital payed Rs 1.1 lacs
to get tuition coaching for his daughter and then arranged
(with great humiliation) Rs 20 lacs for capitation at a private
medical college. I happened to meet this young budding
doctor after 2 years into his college and asked him how is life?
The answer slipped ground under my feet- ‘uncle am waiting
exit from the college so that I can earn the amount my father spent
on my fees’.
(I felt that this boy has already developed apathy to-
wards the society which has put his parents into a fix.) Youcan imagine what agony this student would have under-
gone at his home hearing his parents discuss ways and
means to arrange money for his admission into a medical
college. How terrible those vicarious travails must have
been for him!
This event actually summarises the impact of commer-
cialisation of medical educational on the youngsters and
the perpetuation of business like attitude in them-a de-
parture from the soft and kind hearted care provider atti-
tude. Let us remember that most of these private
institutions are owned either by politicians and rich busi-
nessman or the “opinion leaders” of this society. When it
comes to fleecing capitation fees for the seats in manage-
ment quota, they consider it as their rightful earning and
when the doctors they produce here indulge in business of
medicine it becomes unethical!2. Impact of self aggrandisation and one-
upmanship e role of industry
Who does not enjoy limelight? In ourmedical profession great
advancements have occurred and industry plays an important
role in these advancements both in terms of developing new
drugs and hardware and provision of funds for the research.
Any product, be it medicine or a device once developed needs
to be tested and researched. Again the ‘first’ or ‘amongst the
first users’ gets fillip from the industryehe/she is projected as a
